CEDAR KNOLLS, N.J., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) (the "Company") announced today that management will host a conference call to discuss the Company's financial and operational results for the second quarter ended June 30, 2012 on Tuesday, August 7, 2012 at 10:00 AM ET. A press release will be issued prior to market open.
The live webcast of the conference call can be accessed through the company's web site at: www.emisphere.com. The live conference call dial-in number is: 1-888-857-6932 (United States and Canada) or 1-719-457-1529 (International). In addition, an archive of the webcast can be accessed through the same link and an audio replay of the call will be available beginning at 1:00 PM ET on August 7, 2012 through 1:00 AM ET on August 23, 2012 by calling 1-888-203-1112 (United States and Canada) or 1-719-457-0820 (International). The conference replay PIN is 7575840.
About Emisphere Technologies, Inc.
Emisphere is a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds, medical foods and dietary supplements using its Eligen(R) Technology. These molecules and compounds could be available currently or are under development. Such molecules are usually delivered by injection; in many cases, their benefits are limited due to poor bioavailability, slow on-set of action or variable absorption. The Eligen(R) Technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. The company's website is: www.emisphere.com.
CONTACT: Michael R. Garone - Interim CEO, CFO
973.532.8005 or firstname.lastname@example.org